Angioimmunoblastic T-cell lymphoma (AIL-TCL) following macrolide administration.

dc.contributor.authorSasaki, T Y
dc.contributor.authorSumida, Kenneth N. M.
dc.date.accessioned2016-10-25T23:17:06Z
dc.date.available2016-10-25T23:17:06Z
dc.date.issued2000-02
dc.description.abstractAngioimmunoblastic Lymphadenopathy with Dysproteinemia (AILD) is a rare benign reactive process which often follows exposure to certain drugs such as penicillin. Treatment with corticosteroids usually reverses the process, however there have been reports of 18% of cases evolving into non-Hodgkins lymphoma. In our case report, we present a relatively healthy woman with history of various drug hypersensitivities who developed AILD and resultant lymphoma after treatment with azithromycin. A review of the literature has failed to find reports of AILD following macrolide exposure. Clonality, not present in other forms of hyperplasia, is present in AILD and immunosuppression may account for this difference. It is difficult to say whether the drugs are simply coincidently associated or actually cause, maintain, or exacerbate clonality in AILD and facilitate malignant transformation.
dc.identifier.issn0017-8594
dc.identifier.pubmed10800250
dc.identifier.urihttp://hdl.handle.net/10524/53861
dc.language.isoeng
dc.subject.meshAged
dc.subject.meshAnti-Bacterial Agents/adverse effects
dc.subject.meshAzithromycin/adverse effects
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshImmunoblastic Lymphadenopathy/complications
dc.subject.meshLymphoma, T-Cell/etiology
dc.titleAngioimmunoblastic T-cell lymphoma (AIL-TCL) following macrolide administration.
dc.typeArticle
dc.type.dcmiText
prism.number2
prism.pagerange44-7, 56
prism.publicationnameHawaii Medical Journal
prism.volume59

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2000-02p44-56.pdf
Size:
574.16 KB
Format:
Adobe Portable Document Format